|
|
Newsletters
Newsletters
-
DCP Newsletter Edition May 2010
- De Clercq & Partners: The firm
- De Clercq & Partners will be present on numerous events
- G 1/07: Surgical methods
- Dosage regime patent claims are allowable: G 2/08
- Questions to the ECJ regarding embryonic stem cells: The Brüstle case
- Eli Lilly v Human Genome Sciences: UK Court of Appeal v EPO on Article 57 EPC.11
- G 4/08: use of languages
- Important changes in the Rules of the EPC entering into force on April 1, 2010: Time limit of filing of Divisional applications
-
DCB Newsletter Edition April 2009
- Important changes in the Rules of the EPC
- New EPO fee structure as of April 1, 2009
- DCB News
-
DCB Newsletter Edition January 2009
- The Firm
- Six year patent abolished in The Netherlands
- Six year patent abolished in Belgium as from January 1, 2009
- New tax deduction for patent income in Belgium as of taxable income 2007
- Translation in Belgium of European patents granted in German
- London Agreement in Belgium
- London Agreement in The Netherlands
- No European patents on human embryonic stem cells
- Referral to the Enlarged Board of Appeal regarding surgical methods G 1/07
- Referral to the Enlarged Board of Appeal regarding dosage regime pharmaceutical patents G 2/08
- Referral to the Enlarged Board of Appeal regarding computer implemented inventions G 3/08
- European Commission Preliminary Report on Pharmaceutical Sector Inquiry
-
Special Edition - EPC 2000 - October 2007
- EPC 2000: Effects in Belgium
- New provisions relating to filing (Art. 14 EPC, Art. 79 EPC)
- Medical treatment and diagnostic methods (Article 53(c) EPC)
- First, second and further medical indications (Article 54(4) and 54(5) EPC)
- Novelty
- Claiming priority from WTO countries (Article 87 EPC)
- Central limitation procedure (new Articles 105a, 105b, 105c EPC)
- Amending claims in national revocation proceedings always allowed (Article 138 EPC)
- Further processing and re-establishment of rights (restitutio in integrum) (Article 121 and 122 EPC)
- Referrals to the Enlarged Board of Appeal (Article 112a EPC)
- Interpretation of claims (Article 69 EPC and Protocol on Interpretation)
-
Volume III Issue I - September 2006
- Referral to EBA regarding embryonic stem cell patents
- Referrals to EBA relating to divisional applications
- ECJ overrules Advocate General in SPC case
- New regulation on compulsory licensing of patents relating to manufacture of pharmaceutical products for export to countries with health problems
- EPO case elevates threshold for passing inventive step requirement
- A method of operating a computer is not a computer program
- EPO Boards of Appeal continue to struggle with inventive step and technical character concepts for computer implemented inventions
- Two important rulings of ECJ affect international litigation strategies
-
Special Edition - BIO 2006 Chicago - March 2006
- The firm
- EPO decision on diagnostic methods, G 0001/04
- Embryonic stem cells, referral to the Enlarged Board of appeal
- EPO rules on second and further medical indication, further narrowing medical treatment exception
- ECJ opinion Advocate-General Léger relating to the scope of SPC and formulations
- European Commission continues to monitor transposition Biotech Directive
- Bolar type exception for generics now also in the EU
- Belgium introduced broad experimental use exception in Patents Act page
- European Patent litigation Agreement (EPLA)
-
Volume II Issue I - January 2005
- Our November 2004 seminar
- Belgium convicted by ECJ
- Bill implementing biotech directive in Belgian Parliament
- Oncomouse case has been decided
- Swiss proposal to amend PCT in connection with disclosure of origin of biological material
- The EC computer patent soap continues
- New EPO decision relating to computer-implemented inventions
-
Volume I Issue III - June 2004
- About De Clercq Brants & Partners
- Recent developments in European Intellectual Property Law
- The Biotech Directive
- BRCA1 gene patent EP 0 699 754 revoked by Opposition Division
- Stem Cell Patents
- Computer Implemented Inventions
- Enlarged Board of Appeal decision in the Disclaimer Cases
- Diagnostic Methods before the Board of Appeal
- The Community Patent
- Enforcement Directive
- Bolar Type of exception also in Europe
- New EU block exemption regulation 772/2004 on Technology Transfer
- ECJ Decision on copyright compulsary licensing
-
Volume I Issue II - April 2004
- Referral to the Enlarged Board of Appeal concerning diagnostic methods
- Enlarged Board of Appeal decision in the Disclaimer Cases, G 01/03, G 02/03
- Hearings for BRCA Patent Oppositions scheduled on April 17, 2004
- Community Patent not yet reality
- Announcement
-
Volume I, Issue I - January 2004
- Announcement
- Featured article: Europe gets its own Bolar-type exception for generic drugs
- PCT reform - Convention update
- EPO partially lifts the limitation on competence as a PCT authority for US biotechnolgy patent applications
|
|
|
Edition May 2010